A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

NCT06925100 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia or Mixed Hyperlipidemia

Interventions

DRUG: Bempedoic acid 180 mg tablet

Sponsor

Daiichi Sankyo